NCT00132899View on ClinicalTrials.gov

COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

July 31, 2008

Conditions
Crohn's Disease
Interventions
DRUG

Methotrexate

Methotrexate and infliximab combination

DRUG

Placebo

Placebo and infliximab combination therapy.

Trial Locations (1)

N6A 5K8

Robarts Clinical Trials, Robarts Research Institute, London

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

University of Western Ontario, Canada

OTHER

NCT00132899 - COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) | Biotech Hunter | Biotech Hunter